Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Steven Clifton"'
Autor:
Maria Beconi, Omar Aziz, Kim Matthews, Lara Moumné, Catherine O'Connell, Dawn Yates, Steven Clifton, Hannah Pett, Julie Vann, Lynsey Crowley, Alan F Haughan, Donna L Smith, Ben Woodman, Gillian P Bates, Fred Brookfield, Roland W Bürli, George McAllister, Celia Dominguez, Ignacio Munoz-Sanjuan, Vahri Beaumont
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44498 (2012)
Histone deacetylase (HDAC) inhibitors have received considerable attention as potential therapeutics for a variety of cancers and neurological disorders. Recent publications on a class of pimelic diphenylamide HDAC inhibitors have highlighted their p
Externí odkaz:
https://doaj.org/article/65e55963f962453d81bddb172d9b42fa
Autor:
Mark Eddy, Steven Clifton, Jerone Cecelic, Julie Packard, Alan Yuspeh, Jill Fainter, Susan Postal, Kathleen Whalen, Lisa Cobb, Paula Waddey, Joe Steakley
Publikováno v:
Frontiers of Health Services Management. 16:3-38
How can a healthcare organization improve the public's confidence in the conduct of its business operations? What can it do to ensure that it can thrive despite being the subject of public and governmental scrutiny and doubt? Healthcare providers mus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::842616053680c27e2c785db353e9609e
https://doi.org/10.1097/01974520-199910000-00002
https://doi.org/10.1097/01974520-199910000-00002
Autor:
Vlad, Steven Clifton
Thesis (Ph.D.)--Boston University
Since glucocorticoids first were discovered and then synthesized in the 1940s, they have revolutionized the treatment of a wide variety of medical conditions. Unfortunately, they also have a very large number of
Since glucocorticoids first were discovered and then synthesized in the 1940s, they have revolutionized the treatment of a wide variety of medical conditions. Unfortunately, they also have a very large number of
Externí odkaz:
https://hdl.handle.net/2144/11077
Autor:
Lynsey Crowley, Dawn Yates, Ignacio Munoz-Sanjuan, Julie Vann, Fred Brookfield, Hannah Pett, George McAllister, Gillian P. Bates, Roland Burli, Catherine M. O'Connell, Celia Dominguez, Kim L. Matthews, Ben Woodman, Omar Aziz, Alan Findlay Haughan, Donna L. Smith, Maria Beconi, Steven Clifton, Lara Moumné, Vahri Beaumont
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 9, p e44498 (2012)
PLoS ONE, Vol 7, Iss 9, p e44498 (2012)
Histone deacetylase (HDAC) inhibitors have received considerable attention as potential therapeutics for a variety of cancers and neurological disorders. Recent publications on a class of pimelic diphenylamide HDAC inhibitors have highlighted their p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61899a347b9b8ee1c607929b27cc12ff
https://pubmed.ncbi.nlm.nih.gov/22973455
https://pubmed.ncbi.nlm.nih.gov/22973455